Search - tctmd.com

Displaying 121 - 140 of 163

Sort: Relevancy | Date

News Daily News

Echo Overuse in Heart Failure Stabilizes in the Wake of Ontario Appropriateness Efforts

Michael O'Riordan

August 09, 2019

News Industry News

U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure

June 26, 2019

News Features ESC Heart Failure 2019

At the ESC Heart Failure Congress, Some COAPT Converts—and Some Pushback

Shelley Wood

May 30, 2019

News Conference News ESC Heart Failure 2019

Weaning Off Diuretics in Stable Heart Failure? ReBIC-1 Hints at Possibilities

Shelley Wood

May 28, 2019

News Daily News

Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor

Michael O'Riordan

April 12, 2019

News Daily News

Artificial Intelligence From ECGs May ID Asymptomatic LV Dysfunction

Todd Neale

January 09, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2018

Caitlin E. Cox

January 01, 2019

News Conference News AHA 2018

DECLARE-TIMI 58 Supports HF Benefit of SGLT2 Inhibitors

Todd Neale

November 10, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

News Conference News ESC 2018

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Michael O'Riordan

August 29, 2018

News Conference News ESC 2018

MITRA-FR: No Benefit of MitraClip in Functional MR

Shelley Wood

August 27, 2018

News Daily News

Class I Recall for Medtronic’s HeartWare HVAD System

Michael O'Riordan

June 04, 2018

News Daily News

Quicker Diuretics Not Associated With Better Outcomes in Acute Heart Failure

Todd Neale

March 25, 2018

News Daily News

Surprising Rate of Cardiac Amyloidosis in TAVR Patients Poses Tough Questions for Diagnosis, Decision-Making

Michael O'Riordan

February 01, 2018

News Opinion Editor's Corner TCT 2017

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Shelley Wood

November 22, 2017

Presentation TCT 2017

First of the Class: Tissue Engineering

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Andreu M Climent

October 31, 2017

Presentation TCT 2017

New Strategies for a Chronic Scenario: Combinative Approaches

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Amit N. Patel

October 31, 2017

Presentation TCT 2017

New Products: Ixmyelocel and Allogeneic Mesenchymal Stem Cells

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Timothy D. Henry

October 31, 2017

Presentation TCT 2017

New Targets: Heart Failure With Preserved Ejection Fraction

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Eugenio Cingolani

October 31, 2017

Presentation TCT 2017

In Which Direction is Cell Based Heart Failure Therapy Headed?

Presenter: Francisco Fdez-Aviles, Emerson C. Perin

October 31, 2017

Advertisement

Echo Overuse in Heart Failure Stabilizes in the Wake of Ontario Appropriateness Efforts

U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure

At the ESC Heart Failure Congress, Some COAPT Converts—and Some Pushback

Weaning Off Diuretics in Stable Heart Failure? ReBIC-1 Hints at Possibilities

Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor

Artificial Intelligence From ECGs May ID Asymptomatic LV Dysfunction

TCTMD’s Top 10 Most Popular Stories for December 2018

DECLARE-TIMI 58 Supports HF Benefit of SGLT2 Inhibitors

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

MITRA-FR: No Benefit of MitraClip in Functional MR

Class I Recall for Medtronic’s HeartWare HVAD System

Quicker Diuretics Not Associated With Better Outcomes in Acute Heart Failure

Surprising Rate of Cardiac Amyloidosis in TAVR Patients Poses Tough Questions for Diagnosis, Decision-Making

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

First of the Class: Tissue Engineering

New Strategies for a Chronic Scenario: Combinative Approaches

New Products: Ixmyelocel and Allogeneic Mesenchymal Stem Cells

New Targets: Heart Failure With Preserved Ejection Fraction

In Which Direction is Cell Based Heart Failure Therapy Headed?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content